Conmed (CNMD) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.39% |
| Dec 31, 2025 | 10.00% |
| Sep 30, 2025 | 4.44% |
| Jun 30, 2025 | 21.23% |
| Mar 31, 2025 | 8.33% |
| Dec 31, 2024 | 6.92% |
| Sep 30, 2024 | 6.59% |
| Jun 30, 2024 | 6.97% |
| Mar 31, 2024 | 7.21% |
| Dec 31, 2023 | 6.55% |
| Sep 30, 2023 | 8.72% |
| Jun 30, 2023 | 7.98% |
| Mar 31, 2023 | 7.23% |
| Dec 31, 2022 | 1.24% |
| Sep 30, 2022 | 8.13% |
| Jun 30, 2022 | 7.72% |
| Mar 31, 2022 | 6.37% |
| Dec 31, 2021 | 7.82% |
| Sep 30, 2021 | 7.05% |
| Jun 30, 2021 | 6.67% |
| Mar 31, 2021 | 5.62% |
| Dec 31, 2020 | 5.77% |
| Sep 30, 2020 | 7.40% |
| Jun 30, 2020 | -5.11% |
| Mar 31, 2020 | 5.25% |
| Dec 31, 2019 | 6.42% |
| Sep 30, 2019 | 6.18% |
| Jun 30, 2019 | 5.36% |
| Mar 31, 2019 | 3.43% |
| Dec 31, 2018 | 3.56% |
| Sep 30, 2018 | 3.00% |
| Jun 30, 2018 | 2.47% |
| Mar 31, 2018 | 1.30% |
| Dec 31, 2017 | 2.93% |
| Sep 30, 2017 | 0.93% |
| Jun 30, 2017 | 0.97% |
| Mar 31, 2017 | -0.20% |
| Dec 31, 2016 | 2.09% |
| Sep 30, 2016 | 2.08% |
| Jun 30, 2016 | 2.29% |
| Mar 31, 2016 | 0.42% |
| Dec 31, 2015 | 2.40% |
| Sep 30, 2015 | 1.01% |
| Jun 30, 2015 | -0.04% |